Tuesday, September 15, 2026

The Puppet Dictator: Kim Jong Un REFUSES Trump Meeting Until Russia Gives Him Permission to Talk

North Korea's Choe Son-hui visits Russia amid Trump's openness to a summit, raising questions about diplomatic strategies and future talks.

Boycott Hits Tesla Globally, But China Remains an Unlikely Sanctuary

A global Tesla boycott grows, but China supports Musk. Sales drop in Germany and Canada, while Musk remains popular in China.

“Ioniq 5 Robotaxi to Operate in U.S. Cities”… Motional Launches Pilot Service With Uber

Motional, a Hyundai Motor Group joint venture, launches a robo-taxi pilot service with Uber in Las Vegas.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

SK Biopharm’s Epilepsy Drug Trial Partially Halted in U.S., New Enrollment Suspended

SK Biopharm's U.S. trials of epilepsy drug candidate opicopalim have been partially placed on hold by the FDA, temporarily stopping new enrollment while existing patients continue treatment.

Korean Doctor Wins Top U.S. ENT Research Award, Paving New Path for Sinusitis Treatment

Kyung Hee University professor Min Jin-young won a prestigious U.S. otolaryngology research award for identifying a new sinusitis mechanism and developing a potential low-cost, personalized treatment strategy.

Korean Obesity Drug Set to Launch Next Month as Hanmi’s Efe Targets Market

Hanmi Pharmaceutical plans to launch its domestically developed GLP-1 obesity drug Efe as early as next month, with Korean clinical data, safety and domestic production as key selling points.

Handok Positions Sleep Care as New Growth Driver, Linking Diagnosis, Treatment and Management

Handok is positioning sleep as a new digital health care growth driver by connecting diagnosis, treatment and everyday management through technologies such as digital therapeutics and AI-based sleep monitoring.

How AmorePacific’s New Microbiome Extract Could Revolutionize Acne Scar Treatment

Amorepacific confirms its proprietary microbiome strain extract may help improve post-acne pigmentation and inflammation.

Top 5 Promising Lung Cancer Treatments Revealed at WCLC 2026: What You Need to Know

The world's largest conference on lung cancer will be held in Seoul after 19 years, showcasing clinical results from local pharmaceutical firms.

Why the ArtiSential PRO is a Game Changer for Surgeons: 5 Key Features Explained

LIVSMED is expanding its surgical device portfolio, focusing on its flagship product, the multi-joint laparoscopic instrument ArtiSential PRO.

How COLO eDX is Changing Colon Cancer Monitoring: Key Insights from iCRS 2026

Gencurix confirms its blood-based colon cancer test can detect cancer and monitor recurrence post-surgery.

GCCL Expands Global Partnerships at ABP 2026: Insights into Asia-Pacific Biotech Growth

GCCL, a global clinical trial specimen analysis firm, expanded its collaboration at the Asia Bio Partnering Forum 2026 in Singapore.

Seers to Highlight Earnings Growth, Global Business at Singapore NDR

Seers will use its first Singapore NDR since listing to showcase earnings growth and accelerate global expansion of its AI-powered medical monitoring and diagnostics business.

3billion Accelerates Global Expansion of AI Genetic Variant Interpretation Platform ZEBRA

3billion is accelerating the global expansion of its ZEBRA AI genetic variant interpretation platform by improving reliability, accessibility and clinical adoption across domestic and international medical and research institutions.

What Led to the Supreme Court’s Decision on Medical Liability in a Child’s Severe Drug Reaction?

A Supreme Court ruling states that doctors cannot be held criminally liable for not diagnosing drug allergy syndrome early in patients with liver failure.

GC BioPharma Pioneers AI-Based mRNA-LNP Vaccine Manufacturing: Smart Quality Management System to Launch in 2026

GC Biopharma has been selected as the lead research institution for a project on AI-based vaccine manufacturing and quality control.

K-Pharmaceuticals: How to Boost Exports with High-Value Products in 2026

To expand pharmaceutical exports, we must strengthen existing bases while pursuing product differentiation and entry into high-income countries.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.